Comparison of bone mineral density in type II diabetics and non-diabetics using quantitative computed tomography

  • Soban Muhammad Daud Principal Investigator/Author
  • Burhan Rasheed Doctor's Teaching Trust Hospital, Sargodha
  • Saima Rasheed Niazi Medical and Dental College, Sargodha
  • Ameen Hamood Abdo Rageh Mayo Hospital, Lahore.
  • Faisal Masood Sharif Medical and Dental College, Lahore
Keywords: Bone Density, osteoporosis, diabetes mellitus type 2, glycated hemoglobin A, insulin, computed tomography, qct

Abstract

Background: Relationship between osteoporosis and type II diabetes mellitus (T2DM) is complex. Although many studies have been conducted, still it remains a controversial subject. Osteoporosis is diagnosed by measuring bone mineral density and the current gold standard is quantitative computed tomography (QCT). This study aimed to compare the bone mineral density (BMD) in type 2 diabetics and non-diabetics using QCT, and to correlate BMD with duration of disease, Glycated Haemoglobin A  (HbA1c) level, and Serum Insulin level. Methods: This cross-sectional study was conducted between Aug 2016 and Dec 2019 at Radiology Department, Mayo Hospital Lahore. One hundred type 2 DM and 100 healthy individuals were included. BMD, HbA1c, Fasting Blood Sugar and serum insulin levels were measured in all. BMD, HbA1c and Serum Insulin were compared between the cases and controls. Moreover, the correlation between bone mineral densities, duration of disease, HbA1c and serum Insulin level was assessed. Results: A significant difference between HbA1c, fasting blood sugar levels and serum insulin levels of the two groups was noted. However, no significant difference was observed in the QCT scoring of the groups. Osteoporosis was diagnosed in 19 diabetics and 12 healthy individuals. BMD changes significantly correlated with the duration of illness and HbA1c. There was no significant correlation and between BMD and Serum Insulin Levels. Conclusion: BMD shows a significant correlation with duration of diabetes and HbA1c. These factors play a negative impact on BMD in T2DM. There was no significant correlation between serum insulin and BMD.

Pak J Physiol 2021;17(1):41‒5

Author Biographies

Burhan Rasheed, Doctor's Teaching Trust Hospital, Sargodha

Senior Registrar, Department of Radiology

Saima Rasheed, Niazi Medical and Dental College, Sargodha

Assistant Professor, Department of Biochemistry

Ameen Hamood Abdo Rageh, Mayo Hospital, Lahore.

Post-graduate Radiology Resident, Department of Radiology

Faisal Masood, Sharif Medical and Dental College, Lahore

Assistant Professor, Department of Medicine

References

Meo SA, Zia I, Bukhari IA, Arain SA. Type 2 diabetes mellitus in Pakistan: Current prevalence and future forecast. J Pak Medical Assoc 2016;66(12):1637–42.

Wang B, Yang XN. Relationship between DEXA bone mineral density measurement results and serum cytokines as well as insulin resistance in patients with type 2 diabetes mellitus and osteoporosis. J Hainan Med Univ 2017;23(2):151–5.

Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol 2017;13(4):208–19.

Sanches CP, Vianna AG, de Carvalho Barreto F. The impact of type 2 diabetes on bone metabolism. Diabetol Metab Syndr 2017;9:85.

Costantini S, Conte C. Bone health in diabetes and prediabetes. World J Diabetes 2019;10(8):421–45.

Link TM, Kazakia G. Update on Imaging-Based Measurement of Bone Mineral Density and Quality. Curr Rheumatol Rep 2020;22(5):13.

Damilakis J, Adams JE, Guglielmi G, Link TM. Radiation exposure in X-ray-based imaging techniques used in osteoporosis. Eur Radiol 2010;20(11):2707–14.

Link TM. Osteoporosis imaging: state of the art and advanced imaging. Radiology 2012;263(1):3–17.

Mao SS, Li D, Syed YS, Gao Y, Luo Y, Flores F, et al. Thoracic quantitative computed tomography (QCT) can sensitively monitor bone mineral metabolism: comparison of thoracic QCT vs lumbar QCT and dual-energy X-ray absorptiometry in detection of age-relative change in bone mineral density. Acad Radiol 2017;24(12):1582–7.

Oei L, Koromani F, Rivadeneira F, Zillikens MC, Oei EH. Quantitative imaging methods in osteoporosis. Quant Imaging Med Surg 2016;6(6):680–98.

Ziemlewicz TJ, Maciejewski A, Binkley N, Brett AD, Brown JK, Pickhardt PJ. Opportunistic quantitative CT bone mineral density measurement at the proximal femur using routine contrast‐enhanced scans: direct comparison with DXA in 355 adults. J Bone Miner Res 2016;31(10):1835–40.

Yu EW, Thomas BJ, Brown JK, Finkelstein JS. Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT. J Bone Miner Res 2012;27(1):119–24.

Vestergaard P. Diabetes and osteoporosis—cause for concern?. Front Endocrinol (Lausanne) 2014;5:53.

Shan PF, Wu XP, Zhang H, Cao XZ, Yuan LQ, Liao EY. Age-related bone mineral density, osteoporosis rate and risk of vertebral fracture in mainland Chinese women with type 2 diabetes mellitus. J Endocrinol Invest 2011;34(3):190–6.

Ma XH, Zhang W, Wang Y, Xue P, Li YK. Comparison of the spine and hip BMD assessments derived from quantitative computed tomography. Int J Endocrinol 2015;2015:675340.

Antonopoulou M, Bahtiyar G, Banerji MA, Sacerdote AS. Diabetes and bone health. Maturitas. 2013;76(3):253–9.

Adil C, Aydın T, Taşpınar Ö, Kızıltan H, Eriş AH, Hocaoglu IT, et al. Bone mineral density evaluation of patients with type 2 diabetes mellitus. J Phys Ther Sci 2015;27(1):179–82.

Kao CH, Tsou CT, Chen CC, Wang SJ. Bone mineral density in patients with noninsulin-dependent diabetes mellitus by dual photon absorptiometry. Nucl Med Commun 1993;14(5):373–7.

Sosa M, Dominguez M, Navarro MC, Segarra MC, Hernandez D, de Pablos P, et al. Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus. J Diabetes Complications 1996;10(4):201–5.

Kocián J, Brunová J. Diabetic osteopathy. 4. Laboratory findings. Vnitr Lek 1990;36(5):460–6.

Takizawa M, Kameyama K, Maruyama M, Ishida H. Bone loss in type 2 diabetes mellitus‒diabetic osteopenia. Nihon Rinsho 2003;61(2):287–91. [Article in Japanese]

Oei L, Zillikens MC, Dehghan A, Buitendijk GH, Castaño-Betancourt MC, Estrada K, et al. High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study. Diabetes Care 2013;36(6):1619–28.

Bridges MJ, Moochhala SH, Barbour J, Kelly CA. Influence of diabetes on peripheral bone mineral density in men: a controlled study. Acta Diabetol 2005;42(2):82–6.

Mathen PG, Thabah MM, Zachariah B, Das AK. Decreased bone mineral density at the femoral neck and lumbar spine in South Indian patients with type 2 diabetes. J Clin Diagn Res JCDR 2015;9(9):OC08–12.

Jang M, Kim H, Lea S, Oh S, Kim JS, Oh B. Effect of duration of diabetes on bone mineral density: a population study on East Asian males. BMC Endocr Disord 2018;18(1):61.

Downloads

Download data is not yet available.
Published
2021-03-31
How to Cite
1.
Muhammad Daud S, Rasheed B, Rasheed S, Abdo Rageh A, Masood F. Comparison of bone mineral density in type II diabetics and non-diabetics using quantitative computed tomography. PJP [Internet]. 31Mar.2021 [cited 27Jul.2021];17(1):41-5. Available from: https://pjp.pps.org.pk/index.php/PJP/article/view/1222